Etoposide is a potent cytotoxic agent useful in the treatment of vario
us malignancies. Earlier work in our laboratory with this drug as obta
ined from the source (etoposide I) revealed that it undergoes thermal
transitions during the course of heating to 300 degrees C. In this stu
dy these thermal events were characterized by subjecting etoposide I t
o differential thermal analyses, powder X-ray diffractometry, mass spe
ctrometry, infrared analysis and HPLC. Etoposide I, a monohydrate, was
found to undergo a dehydration reaction in the range of 85-115 degree
s C to yield etoposide Ia, which upon further heating melted at 198 de
grees C and crystallized to a new polymorph, etoposide IIa at 206 degr
ees C. Etoposide IIa was found to melt at 269 degrees C and converted
to its hydrated form, etoposide II, when exposed to the atmosphere at
room temperature. This hydrate was also found to undergo a dehydration
reaction at 90-120 degrees C to yield etoposide IIa. The X-ray diffra
ction studies confirmed the existence of etoposide I, Ia and II, IIa a
s two different crystal arrangements. Nearly identical infrared spectr
a and retention times with the HPLC indicated that the two forms were
not chemically different. The polymorphic transition was found to be i
rreversible and a monotropic type of transition. TGA and mass spectral
analyses of etoposide I and II suggested that the water was present i
n their crystal lattices. Etoposide II was found to have greater aqueo
us solubility than that of etoposide I at 0, 22, and 37 degrees C.